Dr. Evan Lewis
Adult & Child Neurologist
|Concussion/Post-Concussion| |Epilepsy| |Functional Neurological Disorder| |Functional Seizures|
|Cannabis & Psychedelic Medicine - Counselling & Therapy|
Comprehensive & Evidence-Based Neurologic Care
Dr. Lewis prioritizes harm reduction and recognizes the significance of how mental health impacts neurologic diagnoses.
He leverages his expertise in neurology to integrate emerging therapies, delivering individualized, comprehensive neurologic care.
Dr. Lewis’ patient visits occur at Watson Medical Clinic.
561 Eglinton Ave. West
Toronto ON
M5N 1B5
Tel: 416-551-7606
Fax: 647-689-2012
To schedule an appointment, contact the clinic directly or download a referral form for your health team to complete.
For existing patients, contact the clinic to book a follow up.
Note: all new patients require a referral from a physician or nurse practitioner
Schedule an Appointment with Dr. Lewis
About Dr. Evan Lewis
Overview
Dr. Evan Cole Lewis is a Neurologist and Clinical Neurophysiologist with expertise in pediatric neurology and epilepsy. Dr. Lewis is an Assistant Professor (Adjunct) with the Department of Pediatrics at the Hospital for Sick Children and the University of Toronto. At North Toronto Neurology in Toronto, Canada, Dr. Lewis conducts clinical research trials and provides independent medico-legal examinations. He is the co-founder and medical director of Homeward Therapy which provides Psychedelic and Ketamine-Assisted Therapy.
The focus of Dr. Lewis’ clinical work includes:
Epilepsy
Concussion & persisting symptoms after concussion
Functional neurological disorder, in particular functional seizures
Cannabis for neurologic disorders
Psychedelic-Assisted Therapy and Ketamine-Assisted Therapy
Dr. Lewis was the founder of the Neurology Centre of Toronto where he served as medical director from 2016 to 2024. He served as VP Psychedelic Neurology for Numinus from 2021 to 2024 and previously was the Chief Medical Advisor for the Jamaican Medical Cannabis Corporation Group.
Dr. Lewis’ research interests lie in the fields of psychedelic and cannabis therapies for neurologic disorders.
Work in Psychedelic Medicines
Dr. Lewis’ clinical and research focus in psychedelic medicine includes indications, treatment and novel approaches. He has clinical experience counselling patients with underlying neurologic conditions who have utilized psychedelics such as psilocybin, MDMA and ketamine. Dr. Lewis utilizes psychedelic-assisted therapy as adjunct treatment for functional neurological disorders, functional seizures, persisting symptoms after concussion, depression, anxiety disorders, co-morbid mental health conditions and special circumstances that arise from neurologic diagnoses. He has delivered educational seminars, talks and lectures on the intersection of psychedelics in neurology both locally and internationally.
Work in Medical Cannabis
Dr. Lewis has significant clinical experience with medical cannabis in adults and children and has spoken extensively on cannabis in neurologic disorders nationally and internationally. He is a member of the Cannabinoid Research Initiative of Saskatchewan (CRIS) and the Canadian Childhood Cannabinoid Clinical Trials (C4T) group. Dr. Lewis was a co-investigator for a medical cannabis trial that treated chronic headaches among adolescents and is part of the steering committee for a clinical trial treating drug-resistant epilepsy in both children and adults.
In the United Kingdom, he is a member of the Expert Committee of the Medical Cannabis Clinicians Society (MCCS) and an advisor for the Medical Cannabis Working Group for Drug Science, Intractable Epilepsy Charity and MedCan.
Link to Publications: https://goo.gl/yLhvN1
